BRIM BIOTECHNOLOGY, INC.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
1. BRM421 for Dry Eye Disease
2. BRM423 for Corneal Damage Repair
3. BRM424 for Neurotrophic Keratitis
4. BRM521 for Treatment of Osteoarthritis
2. BRM423 for Corneal Damage Repair
3. BRM424 for Neurotrophic Keratitis
4. BRM521 for Treatment of Osteoarthritis
The content above was translated by Ai
Founded Year
2013
Unified Business No.
54346233
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,330,990,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2022)、Listing(2024)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
BRIM Biotechnology brings together experts across science, engineering, and technology disciplines to deliver a more efficient, less costly, drug development process. Our talented team has forged decades worth of strong global connections and experience. We operate based on a virtual team model, integrating our expert R&D operation team in Taiwan with our skilled overseas scientific team. We have years of experience working in technological and pharmaceutical development, regulatory affairs, and marketing and IP, with expertise across the field of innovative drug development, including pre-clinical toxicology, clinical pharmacology, and management. We harness the power of our team’s expertise in translational science to deliver a difference for patients.
The content above was translated by Ai
